Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Osteopenia: early-phase trial registry

1 of 10 indexed Osteopenia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 1 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Osteopenia: 10 US clinical trials tracked, 1 recruiting.

Osteopenia is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Duquesne University, running 2 of these trials.

Enrollment posture brief

Registry condition osteopenia

OPEN 1 | RECR 10% | LATE 2 | EARLY 4 | RANK #1724 | SPON 2

Nearest open-share peer: Angina Pectoris (10% recruiting · 10 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%Osteopenia (this)10%
Open-enrollment share among volume-matched conditions near Osteopenia

Osteopenia lists 1 open slots (10% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Osteopenia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Osteopenia is recruiting below its size-band peers.

    1 of 10 indexed trials (10%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Osteopenia research.

    Duquesne University accounts for 2 of 10 trials (20%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Osteopenia trials plan to enrol fewer than 100 people.

    Median target enrolment is 53 among the 10 trials that report a genuine target (sentinel values excluded). 8 of those (80%) plan for fewer than 100 participants.

  4. Osteopenia research is mostly interventional.

    8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 21Phase 42

Open and recent trials

10 total, page 1 of 1

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 1
Phase 4 2

Named interventions

Most-linked intervention names on Osteopenia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

sugar pill Dietary supplement
1 trials
Sham, wearing belt Device
1 trials
Wearable vibration belt Device
1 trials
Calcium Phosphate Drug
1 trials
Calcium carbonate Drug
1 trials
risedronate Drug
1 trials
Vitamin D Drug
1 trials
placebo comparator Other
1 trials

US sites by state

Facility locations filed on Osteopenia trials. A trial with sites in several states counts in each.

Nebraska 3 trials
California 3 trials
Pennsylvania 2 trials
Louisiana 2 trials
Florida 2 trials
Wisconsin 1 trials
New Jersey 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Osteopenia page

10 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Osteopenia condition card totals 10 registered trials; most-linked intervention sugar pill; top US site state Nebraska. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.